Key result
Home blood pressure monitoring had 91% specificity and 55% sensitivity for detecting controlled ambulatory BP, overestimating systolic BP by 8.8 mm Hg (95% CI 6.8-10.7) compared to ABPM.
Why the study?
Does 5-day home blood pressure monitoring accurately diagnose blood pressure control status compared to 24-hour ambulatory blood pressure monitoring in patients with resistant hypertension?
Cross-Sectional (n=240)
Does 5-day home blood pressure monitoring accurately diagnose blood pressure control status compared to 24-hour ambulatory blood pressure monitoring in patients with resistant hypertension?
Mean Difference: 8.8 (95% CI 6.8–10.7)
Home blood pressure monitoring demonstrates good agreement with ambulatory monitoring and can serve as a useful complementary tool in managing resistant hypertension, particularly for identifying patients with controlled ambulatory blood pressure.
Supports home BP monitoring for ruling in control in resistant hypertension; leaves open its accuracy as ABPM substitute given lower sensitivity and overestimation.
BACKGROUND: Ambulatory blood pressure (BP) monitoring (ABPM) is a cornerstone in resistant hypertension (RHT) management. However, it has higher cost and lower patients' acceptance than home BP monitoring (HBPM). Our objective was to evaluate HBPM usefulness in the management of patients with RHT. METHODS: A total of 240 patients were submitted to 24-hour ABPM and 5-day HBPM (triplicate morning and evening measurements). Patients with uncontrolled office BP (≥140/90mm Hg) were classified as true RHT (daytime or home BP ≥135/85mm Hg) or white-coat RHT (daytime or home BP <135/85mm Hg), and patients with controlled office BP were classified as masked RHT (daytime or home BP ≥135/85mm Hg) or controlled RHT (daytime or home BP <135/85mm Hg). Sensitivity, specificity, predictive values, and likelihood ratios for HBPM were calculated. Agreement between the procedures was evaluated using kappa coefficients and the Bland-Altman method. RESULTS: Mean office BP was 157±26/84±16mm Hg, mean daytime BP was 134±18/77±13mm Hg, and mean home BP was 143±20/76±14mm Hg. The ABPM and HBPM diagnoses were 35% and 48%, respectively, for true RHT; 36% and 23%, respectively, for white-coat RHT; 7% and 17%, respectively, for masked RHT; and 22% and 13%, respectively, for controlled RHT. HBPM overestimated systolic BP by 8.8 (95% confidence interval (CI) = 6.8-10.7) mm Hg and diastolic BP by 0.2 (95% CI = -1.0 to 1.4) mm Hg. The specificity, sensitivity, and positive and negative predictive values of HBPM in detecting controlled ambulatory BP were 91%, 55%, 89%, and 59%. CONCLUSIONS: HBPM presented good agreement with ABPM and can be used as a complementary method in the follow-up of resistant hypertensive patients, particularly in those with controlled ambulatory BPs.
No takes yet. Share an insight, caveat, or question.
Muxfeldt et al. (2014) conducted a cross-sectional in Resistant hypertension (n=240). Home blood pressure monitoring (HBPM) vs. Ambulatory blood pressure monitoring (ABPM) was evaluated on Systolic blood pressure difference (MD 8.8, 95% CI 6.8-10.7). Home blood pressure monitoring had 91% specificity and 55% sensitivity for detecting controlled ambulatory BP, overestimating systolic BP by 8.8 mm Hg (95% CI 6.8-10.7) compared to ABPM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: